Letters regarding article by Patti et al, "Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: Results from the ARMYDA-2 (Antiplatelet Therapy for Reduction of MYocardial Damage during Angioplasty) study"

P Tricoci; RA Harrington; M (Marco) Valgimigli

Letters regarding article by Patti et al, "Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: Results from the ARMYDA-2 (Antiplatelet Therapy for Reduction of MYocardial Damage during Angioplasty) study"

P Tricoci, RA Harrington, M (Marco) Valgimigli

Research output: Contribution to journal › Article › Academic › peer-review

4 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	E282-E282
Journal	Circulation
Volume	112
Issue number	17
Publication status	Published - 2005
Externally published	Yes

Cite this

Tricoci, P., Harrington, RA., & Valgimigli, M. (2005). Letters regarding article by Patti et al, "Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: Results from the ARMYDA-2 (Antiplatelet Therapy for Reduction of MYocardial Damage during Angioplasty) study". Circulation, 112(17), E282-E282.

Tricoci, P ; Harrington, RA ; Valgimigli, M (Marco). / Letters regarding article by Patti et al, "Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: Results from the ARMYDA-2 (Antiplatelet Therapy for Reduction of MYocardial Damage during Angioplasty) study". In: Circulation. 2005 ; Vol. 112, No. 17. pp. E282-E282.

@article{1dd8834897884259a818db88952f4450,

title = "Letters regarding article by Patti et al, {"}Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: Results from the ARMYDA-2 (Antiplatelet Therapy for Reduction of MYocardial Damage during Angioplasty) study{"}",

author = "P Tricoci and RA Harrington and Valgimigli, {M (Marco)}",

year = "2005",

language = "Undefined/Unknown",

volume = "112",

pages = "E282--E282",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams & Wilkins",

number = "17",

}

Tricoci, P, Harrington, RA & Valgimigli, M 2005, 'Letters regarding article by Patti et al, "Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: Results from the ARMYDA-2 (Antiplatelet Therapy for Reduction of MYocardial Damage during Angioplasty) study"', Circulation, vol. 112, no. 17, pp. E282-E282.

Letters regarding article by Patti et al, "Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: Results from the ARMYDA-2 (Antiplatelet Therapy for Reduction of MYocardial Damage during Angioplasty) study". / Tricoci, P; Harrington, RA; Valgimigli, M (Marco).
In: Circulation, Vol. 112, No. 17, 2005, p. E282-E282.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Letters regarding article by Patti et al, "Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: Results from the ARMYDA-2 (Antiplatelet Therapy for Reduction of MYocardial Damage during Angioplasty) study"

AU - Tricoci, P

AU - Harrington, RA

AU - Valgimigli, M (Marco)

PY - 2005

Y1 - 2005

M3 - Article

SN - 0009-7322

VL - 112

SP - E282-E282

JO - Circulation

JF - Circulation

IS - 17

ER -

Tricoci P, Harrington RA, Valgimigli M. Letters regarding article by Patti et al, "Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: Results from the ARMYDA-2 (Antiplatelet Therapy for Reduction of MYocardial Damage during Angioplasty) study". Circulation. 2005;112(17):E282-E282.